-
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trialStone GW, Généreux P, Harrington RA et al. -
Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart DiseaseA Czarnecki, F Qiu, G Elbaz-Greener et al.
-
Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome dataEK Oikonomou, M Marwan, MY Desai et al.
-
Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort studySchunk SJ, Zarbock A, Speer T et al.
-
A prospective natural-history study of coronary atherosclerosisStone GW, Maehara A, PROSPECT Investigators.
-
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 TrialsFanaroff AC, Clare R, Pieper KS et al.
-
Advances in Coronary No-Reflow Phenomenon-a Contemporary ReviewKarimianpour A, Maran A.
-
Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery OcclusionsH Kawashima , K Takahashi , the SYNTAX Extended Survival Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
